Ozempic face is the gaunt, hollow, aged appearance that can develop when people lose weight rapidly on GLP-1 medications like semaglutide. It’s not a medical diagnosis but a widely used term describing the sunken cheeks, deeper wrinkles, and sagging skin that result from losing facial fat faster than the skin can adjust. In one small study, researchers found that patients on Ozempic appeared roughly 5 years older than those who weren’t taking the drug.
What Ozempic Face Looks Like
The hallmark is a hollowed-out quality to the face, particularly around the cheeks and temples. Fat sits just beneath the skin of your face and acts like scaffolding, keeping everything looking smooth and full. When that fat disappears quickly, the skin that was stretched over it has nowhere to go. The result is loose, sagging tissue and more visible bone structure, but not in a flattering way.
Specific areas that change most noticeably include the temples (which can look concave), the under-eye area (which appears more sunken), the cheeks (which lose their fullness), and the jawline and neck (where skin starts to droop). Lines running from the nose to the corners of the mouth deepen, and so do the creases that run from the mouth down toward the chin. The overall effect makes someone look significantly older than they did before losing weight, even though they may be healthier by most other measures.
Why It Happens
Your face contains distinct pockets of fat that give it shape and volume. When you lose weight rapidly on a GLP-1 drug, these fat pads shrink dramatically. One study using volumetric imaging on five patients taking Ozempic found that the fat pad at the temples shrank by an average of 42%, while the cheek fat pad shrank by nearly 70%. That’s an enormous change in a relatively short period.
The deeper issue is that your skin can’t keep up. Two key proteins, collagen and elastin, give skin its structure and stretchiness. Rapid weight loss reduces levels of both. So the skin doesn’t snap back the way it might with slower, more gradual changes. Instead, it sags and bunches, creating wrinkles and folds that weren’t there before.
There’s an important nuance here: researchers aren’t sure whether GLP-1 drugs specifically target facial fat or whether any rapid weight loss would produce the same effect. The current evidence leans toward the latter. These medications likely just accelerate and amplify the natural process of age-related facial fat loss. As people get older, elastin production slows down and facial fat naturally thins. Losing 30 or 40 pounds in a few months essentially fast-forwards that process by years.
It’s Not Just About the Face
Ozempic face gets the most attention because it’s the most visible, but GLP-1 medications can affect skin and hair more broadly. The American Academy of Dermatology notes that patients on these drugs have reported thinning hair (a condition called telogen effluvium, triggered by the stress of rapid weight loss), dry skin from hormonal shifts and reduced water intake, brittle nails, excessive sweating, and acne breakouts. Loose skin elsewhere on the body can fold on itself and cause rashes. These side effects stem from the same underlying cause: the body adjusting to fast, significant changes in weight and metabolism.
How to Reduce the Risk
The single most effective strategy is losing weight more slowly. The faster the fat disappears, the less time skin has to remodel itself. Dermatologists recommend working with your prescriber to titrate the medication gradually rather than jumping to the highest dose. This won’t eliminate facial volume loss entirely, but it gives your skin a better chance of adapting.
Staying well hydrated matters because dehydration makes skin look thinner and less elastic. Eating enough protein supports collagen production, and many people on GLP-1 drugs eat far less overall, which can leave them short on the building blocks skin needs to maintain itself. Sun protection is also relevant: UV damage breaks down collagen and elastin, compounding the problem.
If you’re prone to hair loss, dermatologists suggest getting a baseline evaluation before starting a GLP-1 medication so your doctor can adjust treatments preemptively and track any changes.
Treatments for Existing Volume Loss
For people who already have noticeable facial hollowing, the most common non-surgical approach is injectable fillers. These fall into two categories. Hyaluronic acid fillers (like Restylane Lyft) add volume immediately by physically filling in hollow areas. Collagen-stimulating fillers (like Sculptra, made from poly-L-lactic acid) work more gradually by prompting your body to rebuild its own collagen over weeks to months.
A phase 4 clinical study found that combining both types, using Sculptra alongside a hyaluronic acid filler, effectively corrected facial contour changes from medication-driven weight loss and improved skin quality. Treatment typically involves multiple sessions over about two months. Results from hyaluronic acid fillers are temporary, lasting roughly 12 to 18 months, while collagen stimulators can last longer but require patience as the body builds new tissue.
For more severe cases, facial fat grafting is a surgical option. A plastic surgeon harvests fat from another part of your body via liposuction, processes it, and injects it into the face. Unlike fillers, fat grafting is considered a permanent solution, though only about 60% of the transferred fat survives long-term. Injecting platelet-rich plasma at the same time improves fat survival rates. Some surgeons also use small amounts of botulinum toxin near the graft site to reduce movement that could break down the newly placed fat.
A traditional facelift or lower facelift can address skin laxity directly by removing excess skin and tightening the underlying tissue. This is typically reserved for people with significant sagging that fillers alone can’t correct.
Who Is Most Affected
Ozempic face tends to be more noticeable in people over 40, because their skin has already lost some elastin and collagen with age. Someone in their twenties losing the same amount of weight will generally have better skin rebound. People who lose larger amounts of weight, and those who lose it very quickly, are also at higher risk. Naturally lean faces with less fat to begin with can look particularly dramatic after even modest additional loss.
It’s worth noting that facial volume loss happens with any type of significant weight loss, whether from medication, bariatric surgery, or diet and exercise alone. The reason it’s become so closely associated with Ozempic and similar drugs is the speed and scale of weight loss these medications produce, combined with how many people are now taking them.